Transcriptional suppression of the IGF-1R gene by BRCA1 has also been reported in breast and endometrial cancer, and loss-of-function mutation of BRCA1 leads to amplification [44–46] and constitutive activation of the IGF-1R pathway in breast cancer [13–15]. The gene discussed is IGF1R; the disease is breast carcinoma.